Author(s): Kusari S, Singh S, Jayabaskaran C
Abstract Share this page
Abstract The potential of endophytes, particularly endophytic fungi, capable of demonstrating desirable functional traits worth exploitation using red biotechnology is well established. However, these discoveries have not yet translated into industrial bioprocesses for commercial production of biopharmaceuticals using fungal endophytes. Here, we define the current challenges in transforming curiosity driven discoveries into industrial scale endophyte biotechnology. The possible practical, feasible, and sustainable strategies that can lead to harnessing fungal endophyte-mediated pharmaceutical products are discussed. Copyright © 2014 Elsevier Ltd. All rights reserved.
This article was published in Trends Biotechnol
and referenced in Journal of Plant Pathology & Microbiology